Edema related to treatment with psychotropic drugs.
AMSP program
Adverse drug reaction
Edema
Mirtazapine
Pregabalin
Psychotropic drugs
Journal
Journal of neural transmission (Vienna, Austria : 1996)
ISSN: 1435-1463
Titre abrégé: J Neural Transm (Vienna)
Pays: Austria
ID NLM: 9702341
Informations de publication
Date de publication:
14 Feb 2024
14 Feb 2024
Historique:
received:
04
11
2023
accepted:
02
01
2024
medline:
14
2
2024
pubmed:
14
2
2024
entrez:
14
2
2024
Statut:
aheadofprint
Résumé
Edema as an adverse drug reaction is a commonly underestimated yet potentially debilitating condition. This study analyzes the incidence of severe psychotropic drug-induced edema (e.g., edema affecting the face, legs, or multiple body parts and lasting for more than 1 week, or in any case necessitating subsequent diuretic use) among psychiatric inpatients. The cases under examination are derived from an observational pharmacovigilance program conducted in German-speaking countries ("Arzneimittelsicherheit in der Psychiatrie", AMSP) from 1993 to 2016. Among the 462,661 inpatients monitored, severe edema was reported in 231 cases, resulting in an incidence of 0.05%. Edema occurred more frequently in women (80% of all cases) and older patients (mean age 51.8 years). Pregabalin had the highest incidence of severe edema, affecting 1.46‰ of patients treated with pregabalin, followed by mirtazapine (0.8‰). The majority of edema cases showed a positive response to appropriate countermeasures, such as dose reduction and drug discontinuation, and resolved by the end of the observation period. While most instances of drug-induced edema are reversible, they can have a significant impact on patient well-being and potentially result in decreased treatment adherence. It is, therefore, crucial to remain vigilant regarding risk-increasing circumstances during treatment with psychotropic drugs.
Identifiants
pubmed: 38353811
doi: 10.1007/s00702-024-02738-6
pii: 10.1007/s00702-024-02738-6
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024. The Author(s).
Références
Anttila Sami AK, Leinonen Esa VJ (2001) A review of the pharmacological and clinical profile of mirtazapine. CNS Drug Rev 7(3):249–264. https://doi.org/10.1111/j.1527-3458.2001.tb00198.x . (ISSN: 1080563X)
doi: 10.1111/j.1527-3458.2001.tb00198.x
pmcid: 6494141
Ashina K, Tsubosaka Y, Nakamura T, Omori K, Kobayashi K, Hori M, Ozaki H, Murata T (2015) Histamine induces vascular hyperpermeability by increasing blood flow and endothelial barrier disruption in vivo. PLoS One 10(7):1–16. https://doi.org/10.1371/journal.pone.0132367 . (ISSN: 19326203)
doi: 10.1371/journal.pone.0132367
Baldwin DS, Den BJA, Lyndon G, Emir B, Schweizer E, Haswell H (2015) Efficacy and safety of pregabalin in generalised anxiety disorder: a critical review of the literature. J Psychopharmacol 29(10):1047–1060. https://doi.org/10.1177/0269881115598411 . (ISSN: 14617285)
doi: 10.1177/0269881115598411
pubmed: 26259772
Bangalore RP, Ravishankar GM, Chittaranjan A (2014) Bilateral peripheral edema as a rare adverse effect of escitalopram. Indian J Psychiatry 56(1):97. https://doi.org/10.4103/0019-5545.124735 . (ISSN: 00195545)
doi: 10.4103/0019-5545.124735
Barrnett J, Frances A, Kocsis J, Brown R, Mann JJ (1985) Peripheral edema associated with trazodone: a report of ten cases. J Clin Psychopharmacol 5(3):161–164 (ISSN: 0271-0749)
doi: 10.1097/00004714-198506000-00008
pubmed: 3998206
Besharat S, Grol-PH Gao S, Feng C, Akwaa F, Gewandter JS (2021) Peripheral edema: a common and persistent health problem for older Americans. PLoS One. https://doi.org/10.1371/journal.pone.0260742 . (ISSN: 19326203)
doi: 10.1371/journal.pone.0260742
pubmed: 34914717
pmcid: 8675752
Bodenstein JJK, Lavin P et al (2022) Psychotropic drugs and adverse kidney effects: a systematic review of the past decade of research. CNS Drugs 36:1049–1077
doi: 10.1007/s40263-022-00952-y
pubmed: 36161425
Charlesworth CJ, Smit E, Lee David SH, Alramadhan F, Odden MC (2015) Polypharmacy among adults aged 65 years and older in the United States: 1988–2010. J Gerontol 70(8):989–995. https://doi.org/10.1093/gerona/glv013 . (ISSN: 1758535X)
doi: 10.1093/gerona/glv013
Chen C-K, Chou Y-H (2004) Amisulpride-associated pedal edema. Eur Psychiatry 19(7):454. https://doi.org/10.1016/j.eurpsy.2004.04.011 . (ISSN: 09249338)
doi: 10.1016/j.eurpsy.2004.04.011
pubmed: 15504658
Cho S, Edwin AJ (2002) Peripheral edema. Am J Med 113(7):580–586. https://doi.org/10.1016/S0002-9343(02)01322-0 . (ISSN: 0002-9343)
doi: 10.1016/S0002-9343(02)01322-0
pubmed: 12459405
de la Sierra A (2009) Mitigation of calcium channel blocker-related oedema in hypertension by antagonists of the renin-angiotensin system. J Hum Hypertens 23(8):503–511. https://doi.org/10.1038/jhh.2008.157 . (ISSN: 09509240)
doi: 10.1038/jhh.2008.157
pubmed: 19148104
Domenic S (2003) Calcium channel blocker-related periperal edema: can it be resolved? J Clin Hypertens. https://doi.org/10.1111/j.1524-6175.2003.02402.x
doi: 10.1111/j.1524-6175.2003.02402.x
ElP Calandre, Rico-VF Slim M (2016) Alpha2delta ligands, gabapentin, pregabalin and mirogabalin: a review of their clinical pharmacology and therapeutic use. Expert Rev Neurother 16(11):1263–1277. https://doi.org/10.1080/14737175.2016.1202764 . (ISSN: 17448360)
doi: 10.1080/14737175.2016.1202764
Ely JW, Osheroff JA, Lee CM, Ebell MH (2006) Approach to leg edema of unclear etiology. JABFM. 148–160. http://www.jabfm.org
European Medicines Agency (2004) Scientific discussion for the approval of Lyrica. Accessed: 20 Apr 2023. https://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Scientific_Discussion/human/000546/WC500046600.pdf
European Medicines Agency (2008) Summary of characteristics - Remeron. Accessed 20 May 2023. https://www.ema.europa.eu/en/medicines/human/referrals/remeron#all-documents-section
European Medicines Agency (2010) Summary of characteristics - Olanazpine Apotex. Accessed 20 May 2023. https://www.ema.europa.eu/en/medicines/human/EPAR/olanzapine-apotex
European Medicines Agency (2014) Summary of product characteristics and package leaflet - Seroquel XR. Accessed 20 May 2023. https://www.ema.europa.eu/en/medicines/human/referrals/seroquel-xr#alldocuments-section
European Medicines Agency (2022) Okedi - EPAR - Product information. Accessed 20 May 2023. https://www.ema.europa.eu/en/medicines/human/EPAR/okedi
Fawcett J, Barkin RL (1998) Review of the results from clinical studies on the efficacy, safety and tolerability of mirtazapine for the treatment of patients with major depression. J Affect Disord 51:267–285
doi: 10.1016/S0165-0327(98)00224-9
pubmed: 10333982
Fogari R, Malamani G, Zoppi A, Preti P, Vanasia A, Fogari E, Mugellini A (2000) Comparative effect of lercanidipine and nifedipine gastrointestinal therapeutic system on ankle volume and subcutaneous interstitial pressure in hypertensive patients: a double-blind. Randomized Parallel-Group Study Curr Ther Res 61(12):850–862
Food and Drug Administration (1997) Remeron (mirtzapine) summary basis of approval. Accessed: 30 Nov 2023. https://www.accessdata.fda.gov/drugsatfda_docs/nda/97/20-415S003_Remeron_Prntlbl.pdf
Freynhagen R, Serpell M, Emir B, Whalen E, Parsons B, Clair A, Latymer M (2015) A comprehensive drug safety evaluation of pregabalin in peripheral neuropathic pain. Pain Practice 15(1):47–57. https://doi.org/10.1111/papr.12146 . (ISSN: 15332500)
doi: 10.1111/papr.12146
pubmed: 24279736
Fumagalli C, Maurizi N, Marchionni N, Fornasari D (2020) beta-blockers: their new life from hypertension to cancer and migraine. Pharmacol Res. https://doi.org/10.1016/j.phrs.2019.104587 . (ISSN: 10961186)
doi: 10.1016/j.phrs.2019.104587
pubmed: 32407957
Greil W, Häberle A, Schuhmann T, Grohmann R, Baumann P (2013) Age and adverse drug reactions from psychopharmacological treatment: data from the AMSP drug surveillance programme in Switzerland. Swiss Med Weekly. https://doi.org/10.4414/smw.2013.13772 . (ISSN: 14243997)
doi: 10.4414/smw.2013.13772
Grohmann R, Engel RR, Ruther E, Hippius H (2004) The AMSP drug safety program: methods and global results. Pharmacopsychiatry (Stuttgart Print). https://doi.org/10.1055/s-2004-815505 . (ISSN: 01763679)
doi: 10.1055/s-2004-815505
Grohmann R, Engel RR, Moller H-J, Ruther E, Velden Vander JW, Stubner S (2014) Flupentixol use and adverse reactions in comparison with other common first- and second-generation antipsychotics: Data from the AMSP study. Eur Arch Psychiatry Clin Neurosci 264(2):131–141. https://doi.org/10.1007/s00406-013-0419-y (ISSN: 09401334)
doi: 10.1007/s00406-013-0419-y
pubmed: 23835526
Ku HL, Su TP, Chou YH (2006) Ziprasidoneassociated pedal edema in the treatment of schizophrenia. Progress Neuro-Psychopharmacol Biol Psychiatry 30(5):963–964. https://doi.org/10.1016/j.pnpbp.2006.01.020
doi: 10.1016/j.pnpbp.2006.01.020
Kuchel O, Hamet P, Cuche JL, Tolis G, Fraysse J, Genest J (1975) Urinary and plasma cyclic adenosine 3, 5-monophosphate in patients with idiopathic edema. J Clin Endocrinol Metab 41(2):282–289. https://doi.org/10.1210/jcem-41-2-282 . (ISSN: 19457197)
doi: 10.1210/jcem-41-2-282
pubmed: 169278
Lahdelma L, Bruin R (1998) The clinical course and resolution of mirtazapine-induced edema. Eur Psychiatry 13(S4):265s–266s. https://doi.org/10.1016/S0924-9338(99)80481-7 . (ISSN: 0924-9338)
doi: 10.1016/S0924-9338(99)80481-7
Largeau B, Cracowski JL, Lengellé C, Sautenet B, Jonville-Béra AP (2021) Drug-induced peripheral oedema: an aetiology-based review. BJCP 87(8):3043–3055. https://doi.org/10.1111/bcp.14752 . (ISSN: 13652125)
doi: 10.1111/bcp.14752
pubmed: 33506982
Largeau B, Bordy R, Pasqualin C, Bredeloux P, Cracowski JL, Lengelle C, Gras-Champel V, Auffret M, Maupoil V, Jonville-Bera AP (2022) Gabapentinoid-induced peripheral edema and acute heart failure: a translational study combining pharmacovigilance data and in vitro animal experiments. Biomed Pharmacother. https://doi.org/10.1016/j.biopha.2022.112807 . (ISSN: 19506007)
doi: 10.1016/j.biopha.2022.112807
pubmed: 35303569
Lohr Joann M, Bush Ruth L (2013) Venous disease in women: epidemiology, manifestations, and treatment. J Vasc Surg 57(4):37S-45S. https://doi.org/10.1016/j.jvs.2012.10.121 . (ISSN: 10976809)
doi: 10.1016/j.jvs.2012.10.121
pubmed: 23522716
Messerli Franz H (2002) Vasodilatory edema: a common side effect of antihypertensive therapy. Curr Cardiol Rep 4:479–482
doi: 10.1007/s11886-002-0110-9
pubmed: 12379167
Munari L, Provensi G, Passani Maria B, Galeotti N, Cassano T, Benetti F, Corradetti R, Blandina P (2015) Brain histamine is crucial for selective serotonin reuptake inhibitors behavioral and neurochemical effects. Int J Neuropsychopharmacol. https://doi.org/10.1093/ijnp/pyv045
doi: 10.1093/ijnp/pyv045
pubmed: 25899065
pmcid: 4648163
Nayak V, Chogtu B, Devaramane V, Bhandary PV (2009) Pedal edema with olanzapine. Indian J Pharmacol 41(1):49–50. https://doi.org/10.4103/0253-7613.48883 . (ISSN: 02537613)
doi: 10.4103/0253-7613.48883
pubmed: 20177583
pmcid: 2825016
Ng B, Postlethwaite A, Rollnik J (2003) Peripheral oedema in patients taking olanzapine. Int Clin Psychopharmacol 18(1):57–59. https://doi.org/10.1097/01.yic.0000048750.53980.69 . (ISSN: 0268-1315)
doi: 10.1097/01.yic.0000048750.53980.69
pubmed: 12490777
Okwudili O (2018) Peripheral edema in psychiatric practice: a case series of an unusual adverse effect of risperidone medication. IJMRHS 7(6):68–74 (ISSN: 2319-5886)
Polat A, Turan H, Gok R, Gunduz N (2019) Quetiapine-induced peripheral edema: case series. Dusunen Adam J Psychiatry Neurol Sci 32(2):167–170. https://doi.org/10.14744/DAJPNS.2019.00023
doi: 10.14744/DAJPNS.2019.00023
Read Stephanie H et al (2021) Evidence of a gabapentinoid and diuretic prescribing cascade among older adults with lower back pain. J Am Geriatri Soc 69(10):2842–2850. https://doi.org/10.1111/jgs.17312 . (ISSN: 15325415)
doi: 10.1111/jgs.17312
Robertson D, Biaggioni I, Burnstock G, Low PA (2004) Primer on the autonomic nervous system, pp. 157–161. ISBN: 0-12-589762-6
Semel David T, Kevin M, Gergana Z, Raymond C, Birol Emir (2010) Evaluation of the safety and efficacy of pregabalin in older patients with neuropathic pain: results from a pooled analysis of 11 clinical studies. BMC Family Practice. https://doi.org/10.1186/1471-2296-11-85 . (ISSN: 14712296)
doi: 10.1186/1471-2296-11-85
pubmed: 21054853
pmcid: 2988717
Sullivan DL (2001) Peripheral edema associated with mirtazapine. The annals of pharmacotherapy, pp. 1494. www.theannals.com
Sunder M, Chang AR, Henry RR (2003) Thiazolidinediones, peripheral edema, and type 2 diabetes: incidence, pathophysiology, and clinical implications. Endocr Pract 9:406–416. https://doi.org/10.4158/EP.9.5.406
doi: 10.4158/EP.9.5.406
Tamam L, Ozpoyraz N, Unal M (2002) Oedema associated with risperidone: a case report and literature review. Clin Drug Invest 22(6):411–414. https://doi.org/10.2165/00044011-200222060-00011 . (ISSN: 11732563)
doi: 10.2165/00044011-200222060-00011
Toth C (2014) Pregabalin: latest safety evidence and clinical implications for the management of neuropathic pain. Ther Adv Drug Saf 5(1):38–56. https://doi.org/10.1177/2042098613505614 . (ISSN: 20420994)
doi: 10.1177/2042098613505614
pubmed: 25083261
pmcid: 4110876
Trayes Kathryn P, Studdiford James S, Sarah P, Tully Amber S (2013) Edema: diagnosis and management. AFP/GP 88(2):102–110 (ISSN: 15320650)
Umar Musa U, Abdullahi Aminu T (2016) Self-limiting atypical antipsychotics-induced edema: clinical cases and systematic review. Indian J Psychol Med 38(3):182–188. https://doi.org/10.4103/0253-7176.183089 . (ISSN: 09751564)
doi: 10.4103/0253-7176.183089
pubmed: 27335511
pmcid: 4904752
Valensi P, Behar A, Andre P, Wiernsperger N, Attali JR (1995) The effects of metformin on the capillary permeability to albumin in women patients with cyclic edema. Int J Angiol. https://doi.org/10.1177/000331979504600506
doi: 10.1177/000331979504600506
Weir MR, Rosenberger C, Fink JC (2001) Pilot Study to Evaluate a Water Displacement Technique to Compare Effects of Diuretics and ACE Inhibitors to Alleviate Lower Extremity Edema Due to Dihydropyridine Calcium Antagonists. In: AJH
Whiting E, McCready ME (2016) Pitting and non-pitting oedema. MJA 205(4):157–158. https://doi.org/10.5694/mja16.00416 . (ISSN: 13265377)
doi: 10.5694/mja16.00416
pubmed: 27510340
Wu SC, Crews RT, Skratsky M, Overstreet J, Yalla SV, Winder M, Ortiz J, Andersen CA (2017) Control of lower extremity edema in patients with diabetes: double blind randomized controlled trial assessing the efficacy of mild compression diabetic socks. Diabetes Res Clin Pract 127:35–43. https://doi.org/10.1016/j.diabres.2017.02.025 . (ISSN: 18728227)
doi: 10.1016/j.diabres.2017.02.025
pubmed: 28315576
pmcid: 5429175
Wustmann T, Fiedler T, Gutmann P (2009) Edema related to treatment with olanzapine. Psychiatr Prax 36(3):142–144 (ISSN: 00063223)
doi: 10.1055/s-2008-1067420
pubmed: 18504690
Zaccara G, Gangemi P, Perucca P, Specchio L (2011) The adverse event profile of pregabalin: a systematic review and meta-analysis of randomized controlled trials. Epilepsia 52(4):826–836. https://doi.org/10.1111/j.1528-1167.2010.02966.x . (ISSN: 00139580)
doi: 10.1111/j.1528-1167.2010.02966.x
pubmed: 21320112